| Current Price | $32.35 | Mkt Cap | $2.8B |
|---|---|---|---|
| Open | $34.60 | P/E Ratio | 0.00 |
| Prev. Close | $34.50 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $31.81 - $34.93 | Volume | 1,029,526 |
| 52-Wk Range | $11.67 - $35.41 | Avg. Daily Vol. | 44 |
A development stage nanotechnology company commercializing new technologies in the areas of life sciences, electronics, and energy.
| Current Price | $32.35 | Mkt Cap | $2.8B |
|---|---|---|---|
| Open | $34.60 | P/E Ratio | 0.00 |
| Prev. Close | $34.50 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $31.81 - $34.93 | Volume | 1,029,526 |
| 52-Wk Range | $11.67 - $35.41 | Avg. Daily Vol. | 44 |
The best Bull and Bear pitches based on recency and number of recommendations.
Arrowhead Pharmaceuticals stock rockets 30% after upbeat trial data prompts analyst upgrade,MarketWatch•September 6, 2018MARKET PULSE Shares of Arrowhead Pharmaceuticals Corp. (arwr) rocketed 30% toward a 4 1/2-year high in premarket trade Thursday,… More
“Arrow - Heading” downward.Arrowhead Research Corporation (Arrowhead) is a development stage nanotechnology company, commercializing technologies in the areas of life sciences, electronics and energy. Arrowhead operates four majority-owned… More
Read the most recent pitches from players about ARWR.
Recs
Bigsef77
(68.40)
Submitted: 9/6/2018 11:23:29 AM :
Start Price:
$1.52
NASDAQ:ARWR Score:
+2,003.58
Arrowhead Pharmaceuticals stock rockets 30% after upbeat trial data prompts analyst upgrade
,MarketWatch•September 6, 2018
MARKET PULSE Shares of Arrowhead Pharmaceuticals Corp. (arwr) rocketed 30% toward a 4 1/2-year high in premarket trade Thursday, after upbeat results of the company's treatment for chronic hepatitis B prompted an upgrade at B.
Recs
Quickcard
(< 20)
Submitted: 10/10/2017 5:07:56 PM :
Start Price:
$4.02
NASDAQ:ARWR Score:
+689.22
Pharma companies with what are doing research with verifiable positive results in treatment for especially intractable medical conditions seem to be on a roll. I don't see this should not continue, especially as DNA/RNA research is reaching new highs at the same time.
Recs
motto1628
(58.47)
Submitted: 10/4/2015 2:59:52 AM :
Start Price:
$5.99
NASDAQ:ARWR Score:
+391.05
Functional cure for Hep B
Find the members with the highest scoring picks in ARWR.
mistermiranga (99.72) Score: +2,065.04
The Score Leader is the player with the highest score across all their picks in ARWR.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| mistermiranga | 99.72 | 12/1/2016 |
|
5Y | $1.41 | +2,199.64% | +32.42% | +2,167.22 | 0 Comment | |
| Bigsef77 | 68.40 |
|
|
3Y | $1.52 | +2,025.80% | +22.22% | +2,003.58 | 1 Comment | |
| KidJones | 34.64 | 4/22/2013 |
|
5Y | $1.78 | +1,715.17% | +87.09% | +1,628.08 | 0 Comment | |
| whoodatstockhot | 72.49 | 7/8/2013 |
|
5Y | $2.02 | +1,499.50% | +77.87% | +1,421.64 | 0 Comment | |
| EvilEmpire | 30.52 | 2/28/2013 |
|
5Y | $2.20 | +1,368.64% | +91.87% | +1,276.77 | 0 Comment | |
| MFBurritoSquat | 90.44 | 12/19/2012 |
|
3M | $2.23 | +1,348.88% | +100.27% | +1,248.61 | 0 Comment | |
| hayrettin | 70.66 | 8/24/2017 |
|
5Y | $2.50 | +1,194.99% | +19.18% | +1,175.81 | 0 Comment | |
| beecha | < 20 | 9/19/2017 |
|
5Y | $3.35 | +864.48% | +16.58% | +847.90 | 0 Comment | |
| AJL7 | < 20 | 2/3/2016 |
|
5Y | $3.26 | +891.10% | +52.26% | +838.84 | 0 Comment | |
|
Under5 | < 20 | 9/13/2017 |
|
5Y | $3.42 | +846.12% | +16.59% | +829.53 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
| Player Name | Player Rating |
Start Date |
Call | Time Frame |
Start Price |
Stock Gain |
S&P Gain |
Score | End Date | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| trackchardan | 80.74 | 11/30/2016 |
|
NS | $1.69 | +1,811.83% | +31.50% | +1,780.33 | 0 Comment | |
| TrackJimCramer | 86.47 | 2/26/2015 |
|
3W | $7.74 | +317.44% | +37.88% | -279.56 | 0 Comment | |
| TrackDeutscheSec | 80.19 | 3/5/2014 |
|
NS | $24.99 | +29.29% | +55.26% | -25.97 | 0 Comment | |
| TrackGlobalCrown | < 20 | 4/24/2007 |
|
NS | $61.70 | -92.35% | -6.19% | -86.16 | 4/17/2012 @ $4.72 | 0 Comment |
